Plant-Derived Exosome-Like Nanoparticles: Biological Functions, Therapeutic Applications, and Translational Challenges
Summary
Plant-derived herbal medicines remain important sources of bioactive compounds, but their clinical application is often hindered by poor bioavailability and variable pharmacokinetic profiles. Recent studies have identified plant-derived exosome-like nanoparticles (PELNs) as naturally occurring bioactive nanoparticle preparations containing proteins, lipids, small RNAs, and secondary metabolites.
Keywords
Plant-derived herbal medicines remain important sources of bioactive compounds, but their clinical application is often hindered by poor bioavailability and variable pharmacokinetic profiles. Recent studies have identified plant-derived exosome-like nanoparticles (PELNs) as naturally occurring bioactive nanoparticle preparations containing proteins, lipids, small RNAs, and secondary metabolites. This review examines advances in PELN isolation, biological properties, and their therapeutic applications, with particular emphasis on immune regulation, gut-microbiota modulation, and bone homeostasis. We discuss how isolation and purification approaches affect particle characteristics and the interpretation of biological outcomes. Preclinical studies suggest that PELNs from selected plant sources may modulate osteoblast and osteoclast activities, potentially contributing to bone-remodeling balance. Certain PELN preparations have shown promising characteristics for scalable production, gastrointestinal stability, and oral administration in experimental settings, but these potential advantages are source- and method-dependent and have not been established through systematic comparisons with mammalian exosomes. Interpretation of reported bioactivity is further complicated by inconsistent particle characterization, uncertain vesicular identity and purity, and limited evidence distinguishing vesicle-associated effects from those of co-isolated compounds. Further standardization of isolation, characterization, and dosing is essential for evaluating the clinical potential of PELNs. Pharmacokinetics, biodistribution, and long-term safety also remain insufficiently investigated. Overall, PELNs offer a promising area of plant-based nanomedicine research, but their clinical utility remains to be demonstrated.
Abstract from PubMed Central (PMID 43017206, PMC13753913). This entry was added automatically by our daily literature monitor because it matches the topics we follow; read the full paper at the original source.
Related articles
Orthogonal ensemble and single-particle characterisation of antisense oligonucleotide lipid nanoparticles
Discover nanoLipid nanoparticle-based mRNA delivery system for cancer management
Molecular cancersiRNA-mediated mismatch repair disruption synergizes with oxaliplatin to restore immune surveillance in microsatellite-stable colorectal cancer
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
